Physician profile
Eric O Rasmussen
NPI 1467423376
$4,709.62
in general payments reported to CMS, 2019-2025
11 companies · $778 in 2025
The $778 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,036 · 2022: $1,188 · 2023: $826 · 2024: $882 · 2025: $778.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,628 · Food and Beverage: $758 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,628.00 |
| Food and Beverage | $758.38 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $2,240.45 | 2021-2023 | |
| Abbvie INC. | $1,624.97 | 2022-2025 | |
| Janssen Biotech, INC. | $238.26 | 2022-2024 | Tremfya |
| Amgen INC. | $114.65 | 2023-2024 | Otezla |
| Novartis Pharmaceuticals Corporation | $105.56 | 2023-2024 | |
| Ucb, INC. | $102.17 | 2021-2024 | Bimzelx |
| Pfizer INC. | $81.03 | 2023 | |
| Incyte Corporation | $70.92 | 2023 | Opzelura |
| Dermavant Sciences, INC. | $53.94 | 2023-2024 | Vtama |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $42.12 | 2023 | Targretin |
| Sun Pharmaceutical Industries INC. | $35.55 | 2023-2024 | Ilumya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Rasmussen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.